Success of Repeat Detrusor Injections of Botulinum A Toxin in Patients with Severe Neurogenic Detrusor Overactivity and Incontinence

作者: Joachim Grosse , Guus Kramer , Manfred Stöhrer

DOI: 10.1016/J.EURURO.2004.11.009

关键词: Analysis of varianceAnesthesiaSpinal cord injuryUrologyReflexAdverse effectIn patientMedicineLesionOveractive bladderIncidence (epidemiology)

摘要: Abstract Objectives: Detrusor injections with botulinum toxin type A are an effective treatment for neurogenic detrusor overactivity, lasting 9–12 months. When the patients develop resistance, subsequent might be less effective. Repeat in severe overactivity and incontinence were studied. Methods: Patients received Botox ® (300 UI) or Dysport (750 injections. Clinical variables: satisfaction, anticholinergics use, mean maximum bladder capacity, continence volume. Cystometric parameters: compliance, cystometric reflex Statistics: Anova, χ 2 -tests; t -tests paired ( p =0.05). Results: Forty-three men 23 women (mean age 38.3 years; duration of lesion 9.2 years) included. The interval between (on average 9–11 months) did not change significantly =0.5594). satisfaction was high use decreased substantially =0.0000). Significant improvements found clinical parameters compliance only at second treatment. incidence contractions reduced. Four had transient adverse events after . Conclusions: as first one. cause repeat is relapse overactive symptoms.

参考文章(38)
McCormack Mp, Medico-legal reports. Journal of the Royal Society of Medicine. ,vol. 86, pp. 493- 493 ,(1993)
Scott Ab, Botulinum toxin injection of eye muscles to correct strabismus. Transactions of the American Ophthalmological Society. ,vol. 79, pp. 734- 770 ,(1981)
Mark Hallett, Joseph Jankovic, Therapy with botulinum toxin M. Dekker. ,(1994)
Richard Tidball Johnson, Current Therapy in Neurologic Disease ,(1997)
Paul Abrams, Linda Cardozo, Magnus Fall, Derek Griffiths, Peter Rosier, Ulf Ulmsten, Philip van Kerrebroeck, Arne Victor, Alan Wein, The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourology and Urodynamics. ,vol. 21, pp. 167- 178 ,(2002) , 10.1002/NAU.10052
M Barinaga, Secrets of secretion revealed. Science. ,vol. 260, pp. 487- 489 ,(1993) , 10.1126/SCIENCE.8475382
Antonella Giannantoni, Savino M. Di Stasi, Robert L. Stephen, Pierluigi Navarra, Giorgio Scivoletto, Ettore Mearini, Massimo Porena, Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. The Journal of Urology. ,vol. 167, pp. 1710- 1714 ,(2002) , 10.1016/S0022-5347(05)65183-X
Cristina Sampaio, Joaquim J. Ferreira, Fernanda Simões, Maria J. Rosas, Marina Magalhães, Ana P. Correia, António Bastos-Lima, Rairnundo Martins, Alexandre Castro-Caldas, DYSBOT: A single‐blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1 Movement Disorders. ,vol. 12, pp. 1013- 1018 ,(1997) , 10.1002/MDS.870120627
Joseph Jankovic, Mitchell F. Brin, Botulinum toxin: Historical perspective and potential new indications Muscle & Nerve. ,vol. 20, pp. 129- 145 ,(1997) , 10.1002/(SICI)1097-4598(1997)6+<129::AID-MUS9>3.0.CO;2-B
Klaus V. Toyka, Karlheinz Reiners, Markus Naumann, Max Zellner, Treatment of gustatory sweating with botulinum toxin Annals of Neurology. ,vol. 42, pp. 973- 975 ,(1997) , 10.1002/ANA.410420619